×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
First Wave BioPharma Rebrands To Entero Therapeutics
Contract Pharma
First Wave BioPharma Inc., a late clinical-stage biopharmaceutical company, has changed its name to Entero Therapeutics Inc. and unveiled a...
17 hours ago
First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Market
Yahoo Finance
BOCA RATON, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”),...
6 days ago
ImmunogenX Acquired by First Wave BioPharma
Orrick
First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, has acquired ImmunogenX in an all-stock transaction.
1 month ago
Lowenstein Represents First Wave BioPharma in Acquisition of ImmunogenX
Lowenstein Sandler LLP
Lowenstein Represents First Wave BioPharma in Acquisition of ImmunogenX. Lowenstein represented First Wave BioPharma, Inc. (NASDAQ: FWBI), a...
2 months ago
First Wave BioPharma’s stock more than doubles after deal to sell its IBD treatment
MarketWatch
Shares of First Wave BioPharma Inc. rocketed 123% in premarket trading, which puts them on track for a record one-day gain, after the...
4 months ago
First Wave BioPharma Changes Name to Entero Therapeutics
Yahoo Finance Canada
Rebranding introduced as Company advances toward Phase 3 clinical trial with lead asset – latiglutenase for the treatment of celiac disease...
20 hours ago
First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready ...
GlobeNewswire
First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-...
2 months ago
Why Is First Wave Biopharma (FWBI) Stock Up 148% Today?
InvestorPlace
FWBI stock is soaring after the company tentatively agreed to sell its its potential treatment for inflammatory bowel disease (IBD).
4 months ago
First Wave BioPharma partners with Celiac Journey for Nasdaq event - TipRanks.com
Tipranks
First Wave BioPharma announced that in honor of Celiac Disease Awareness Month in May, it will partner with Celiac Journey, a celiac disease patient...
5 days ago
First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific ...
Yahoo Finance
Paper highlights findings on impact of a gluten-containing diet on serologic status in celiac diseaseBOCA RATON, Fla., April 24,...
3 weeks ago